References
Selikhova M, Fedotova E, Wiethoff S, Schottlaender LV, Klyushnikov S, Illarioshkin SN, Houlden H (2017) A 30-year history of MPAN case from Russia. Clin Neurol Neurosurg 159:111–113. https://doi.org/10.1016/j.clineuro.2017.05.025
Deutschländer A, Konno T, Ross OA (2017) Mitochondrial membrane protein-associated neurodegeneration. Parkinsonism Relat Disord 39:1–3. https://doi.org/10.1016/j.parkreldis.2017.03.014
Olgiati S, Doğu O, Tufekcioglu Z, Diler Y, Saka E, Gultekin M, Kaleagasi H, Kuipers D, Graafland J, Breedveld GJ, Quadri M, Sürmeli R, Sünter G, Doğan T, Yalçın AD, Bilgiç B, Elibol B, Emre M, Hanagasi HA, Bonifati V (2017) The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN. Parkinsonism Relat Disord 39:64–70. https://doi.org/10.1016/j.parkreldis.2017.03.012
Skowronska M, Kmiec T, Jurkiewicz E, Malczyk K, Kurkowska-Jastrzębska I, Czlonkowska A (2017) Evolution and novel radiological changes of neurodegeneration associated with mutations in C19orf12. Parkinsonism Relat Disord 39:71–76. https://doi.org/10.1016/j.parkreldis.2017.03.013
Al Macki N, Al Rashdi I (2017) A novel deletion mutation of exon 2 of the C19orf12 gene in an Omani family with mitochondrial membrane protein-associated neurodegeneration (MPAN). Oman Med J 32(1):66–68. https://doi.org/10.5001/omj.2017.12
Gore E, Appleby BS, Cohen ML, DeBrosse SD, Leverenz JB, Miller BL, Siedlak SL, Zhu X, Lerner AJ (2016) Clinical and imaging characteristics of late onset mitochondrial membrane protein-associated neurodegeneration (MPAN). Neurocase 22(5):476–483
Langwinska-Wosko E, Skowronska M, Kmiec T, Czlonkowska A (2016) Retinal and optic nerve abnormalities in neurodegeneration associated with mutations in C19orf12 (MPAN). J Neurol Sci 370:237–240. https://doi.org/10.1016/j.jns.2016.09.046
Salomão RP, Pedroso JL, Gama MT, Dutra LA, Maciel RH, Godeiro-Junior C, Chien HF, Teive HA, Cardoso F, Barsottini OG (2016) A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging. Arq Neuropsiquiatr 74(7):587–596. https://doi.org/10.1590/0004-282X20160080(review)
Hogarth P (2015) Neurodegeneration with brain iron accumulation: diagnosis and management. J Mov Disord 8(1):1–13. https://doi.org/10.14802/jmd.14034
Yoganathan S, Sudhakar SV, Thomas M, Dutta AK, Danda S (2016) “Eye of tiger sign” mimic in an adolescent boy with mitochondrial membrane protein associated neurodegeneration (MPAN). Brain Dev 38(5):516–519. https://doi.org/10.1016/j.braindev.2015.10.017
Meyer E, Kurian MA, Hayflick SJ (2015) Neurodegeneration with brain iron accumulation: genetic diversity and pathophysiological mechanisms. Annu Rev Genom Hum Genet 16:257–279. https://doi.org/10.1146/annurev-genom-090314-025011
Tschentscher A, Dekomien G, Ross S, Cremer K, Kukuk GM, Epplen JT, Hoffjan S (2015) Analysis of the C19orf12 and WDR45 genes in patients with neurodegeneration with brain iron accumulation. J Neurol Sci 349(1–2):105–9. https://doi.org/10.1016/j.jns.2014.12.036
Amaral LL, Gaddikeri S, Chapman PR, Roy R, Gaddikeri RS, Marussi VH, Bag AK (2015) Neurodegeneration with brain iron accumulation: clinicoradiological approach to diagnosis. J Neuroimaging 25(4):539–551. https://doi.org/10.1111/jon.12195
Hartig M, Prokisch H, Meitinger T, Klopstock T (2013) Mitochondrial membrane protein-associated neurodegeneration (MPAN). Int Rev Neurobiol 110:73–84. https://doi.org/10.1016/B978-0-12-410502-7.00004-1
Acknowledgements
Sequencing was provided by the University of Washington Center for Mendelian Genomics (UW-CMG) and was funded by the National Human Genome Research Institute and the National Heart, Lung and Blood Institute Grant 2UM1HG006493 to Drs. Debbie Nickerson, Michael Bamshad, and Suzanne Leal.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments.
Informed consent
Informed consent was obtained from our patient’s family included in the study.
Rights and permissions
About this article
Cite this article
Kasapkara, Ç.S., Tümer, L., Gregory, A. et al. A new NBIA patient from Turkey with homozygous C19ORF12 mutation. Acta Neurol Belg 119, 623–625 (2019). https://doi.org/10.1007/s13760-018-1026-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-018-1026-5